| Dr Aaron Jon Porter, MD | |
|
3252 Aspen Grove Drive, Suite 1, Franklin, TN 37067-7215 | |
| (615) 771-7555 | |
| (615) 771-7773 |
| Full Name | Dr Aaron Jon Porter |
|---|---|
| Gender | Male |
| Speciality | Ophthalmology |
| Experience | 26 Years |
| Location | 3252 Aspen Grove Drive, Franklin, Tennessee |
| Accepts Medicare Assignments | May be. He may accept the Medicare-approved amount; you may be billed for more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1528058252 | NPI | - | NPPES |
| 64050784 | Medicaid | KY |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207W00000X | Ophthalmology | 37277 (Kentucky) | Secondary |
| 207W00000X | Ophthalmology | MD0000036018 (Tennessee) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Tristar Horizon Medical Center | Dickson, TN | Hospital |
| Logan Memorial Hospital | Russellville, KY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Cataract And Eyecare Center Professional Llc | 7416242979 | 2 |
| Cool Springs Surgical Associates Llc | 3971800319 | 3 |
| Cataract And Eyecare Center Professional Llc | 7416242979 | 2 |
News Archive
Questions abound about what may happen if health care reform does happen.
Horizon Pharma, Inc. announced today that it has filed a registration statement on form S-1 with the U.S. Securities and Exchange Commission ("SEC") relating to a proposed initial public offering of shares of its common stock. All shares of the common stock to be sold in the offering will be offered by the Company.
NexMed, Inc., backed by a revenue generating CRO business and seeking to leverage its proprietary, multi-route NexACT® drug delivery technology and internal pipeline through out-licensing arrangements and partnerships, today announced that the Israel Patent Office has issued an allowance notice for NexMed's patent application entitled, "Topical Compositions for Prostaglandin E1 Delivery."
Politico reports that federal officials made the emergency payment to Verizon Terremark after discovering the federal website was unable to handle sufficient traffic. Also in the news, the Maryland House is scheduled to vote on legislation to provide insurance to people who tried unsuccessfully to buy coverage through the state website.
Two months after the opening of the CDH Proton Center, A ProCure Center, the first patients have "graduated" from their treatment surrounded by family, friends and staff. The group of graduating patients, whose tumors included prostate, brain and a non-cancerous tumor on the spinal cord, received proton therapy, an alternative to standard X-ray radiation that spares healthy tissue and results in far fewer short- and long-term treatment side effects.
› Verified 4 days ago
| Entity Name | Mcpeak Vision Partners Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1801871389 PECOS PAC ID: 5092784033 Enrollment ID: O20040928000085 |
News Archive
Questions abound about what may happen if health care reform does happen.
Horizon Pharma, Inc. announced today that it has filed a registration statement on form S-1 with the U.S. Securities and Exchange Commission ("SEC") relating to a proposed initial public offering of shares of its common stock. All shares of the common stock to be sold in the offering will be offered by the Company.
NexMed, Inc., backed by a revenue generating CRO business and seeking to leverage its proprietary, multi-route NexACT® drug delivery technology and internal pipeline through out-licensing arrangements and partnerships, today announced that the Israel Patent Office has issued an allowance notice for NexMed's patent application entitled, "Topical Compositions for Prostaglandin E1 Delivery."
Politico reports that federal officials made the emergency payment to Verizon Terremark after discovering the federal website was unable to handle sufficient traffic. Also in the news, the Maryland House is scheduled to vote on legislation to provide insurance to people who tried unsuccessfully to buy coverage through the state website.
Two months after the opening of the CDH Proton Center, A ProCure Center, the first patients have "graduated" from their treatment surrounded by family, friends and staff. The group of graduating patients, whose tumors included prostate, brain and a non-cancerous tumor on the spinal cord, received proton therapy, an alternative to standard X-ray radiation that spares healthy tissue and results in far fewer short- and long-term treatment side effects.
› Verified 4 days ago
| Entity Name | Cataract And Eyecare Center Professional Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1073966503 PECOS PAC ID: 7416242979 Enrollment ID: O20201103002466 |
News Archive
Questions abound about what may happen if health care reform does happen.
Horizon Pharma, Inc. announced today that it has filed a registration statement on form S-1 with the U.S. Securities and Exchange Commission ("SEC") relating to a proposed initial public offering of shares of its common stock. All shares of the common stock to be sold in the offering will be offered by the Company.
NexMed, Inc., backed by a revenue generating CRO business and seeking to leverage its proprietary, multi-route NexACT® drug delivery technology and internal pipeline through out-licensing arrangements and partnerships, today announced that the Israel Patent Office has issued an allowance notice for NexMed's patent application entitled, "Topical Compositions for Prostaglandin E1 Delivery."
Politico reports that federal officials made the emergency payment to Verizon Terremark after discovering the federal website was unable to handle sufficient traffic. Also in the news, the Maryland House is scheduled to vote on legislation to provide insurance to people who tried unsuccessfully to buy coverage through the state website.
Two months after the opening of the CDH Proton Center, A ProCure Center, the first patients have "graduated" from their treatment surrounded by family, friends and staff. The group of graduating patients, whose tumors included prostate, brain and a non-cancerous tumor on the spinal cord, received proton therapy, an alternative to standard X-ray radiation that spares healthy tissue and results in far fewer short- and long-term treatment side effects.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Aaron Jon Porter, MD 3252 Aspen Grove Drive, Suite 1, Franklin, TN 37067-7215 Ph: (615) 771-7555 | Dr Aaron Jon Porter, MD 3252 Aspen Grove Drive, Suite 1, Franklin, TN 37067-7215 Ph: (615) 771-7555 |
News Archive
Questions abound about what may happen if health care reform does happen.
Horizon Pharma, Inc. announced today that it has filed a registration statement on form S-1 with the U.S. Securities and Exchange Commission ("SEC") relating to a proposed initial public offering of shares of its common stock. All shares of the common stock to be sold in the offering will be offered by the Company.
NexMed, Inc., backed by a revenue generating CRO business and seeking to leverage its proprietary, multi-route NexACT® drug delivery technology and internal pipeline through out-licensing arrangements and partnerships, today announced that the Israel Patent Office has issued an allowance notice for NexMed's patent application entitled, "Topical Compositions for Prostaglandin E1 Delivery."
Politico reports that federal officials made the emergency payment to Verizon Terremark after discovering the federal website was unable to handle sufficient traffic. Also in the news, the Maryland House is scheduled to vote on legislation to provide insurance to people who tried unsuccessfully to buy coverage through the state website.
Two months after the opening of the CDH Proton Center, A ProCure Center, the first patients have "graduated" from their treatment surrounded by family, friends and staff. The group of graduating patients, whose tumors included prostate, brain and a non-cancerous tumor on the spinal cord, received proton therapy, an alternative to standard X-ray radiation that spares healthy tissue and results in far fewer short- and long-term treatment side effects.
› Verified 4 days ago
Dr. John Moten Omohundro Iii, MD Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 1519 Old Hills Boro Rd, Franklin, TN 37069 Phone: 615-794-7152 | |
Dr. Matthew Lee Hartman, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 393 Nichol Mill Lane, Ste. 30, Franklin, TN 37067 Phone: 615-782-7337 Fax: 423-508-7338 | |
Dr. Robert Selkin, MD Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 2009 Mallory Ln, Suite 220, Franklin, TN 37067 Phone: 888-527-3796 Fax: 972-867-2215 | |
Howard L Beale, M.D. Ophthalmology Medicare: Medicare Enrolled Practice Location: 401 Daffodil Ct, Franklin, TN 37064 Phone: 901-483-1217 Fax: 615-807-1979 | |
Dr. Daniel S Weikert, MD Ophthalmology Medicare: May Accept Medicare Assignments Practice Location: 100 Covey Dr, Suite 107, Franklin, TN 37067 Phone: 615-791-0060 |